Literature DB >> 2545769

Idiopathic isolated ACTH deficiency and the response to CRF.

K J Nowakowski1, J R Tucci.   

Abstract

A 26-year-old woman, intermittently symptomatic over 8 yr, was evaluated for weakness, lightheadedness, and gastrointestinal complaints. She was found to have negligible plasma cortisol and low to low-normal plasma ACTH levels. Although serum cortisol was responsive to ACTH stimulation, metyrapone and insulin-induced hypoglycemia were unable to stimulate pituitary driven adrenal activity. Hypothalamic and pituitary functions were otherwise intact. CRF administration failed to stimulate any increase in plasma ACTH or cortisol levels and CT scanning failed to reveal any anatomic abnormality of the sella or suprasellar areas consistent with an acquired isolated defect in pituitary ACTH secretion. These studies support the impression that the primary defect in isolated idiopathic ACTH deficiency is failure of pituitary ACTH-secreting cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545769     DOI: 10.1007/BF03349975

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  True pituitary Addison's disease, a pituitary unitropic deficiency; fifteen-year follow-up.

Authors:  A STEINBERG; F R SHECHTER; H I SEGAL
Journal:  J Clin Endocrinol Metab       Date:  1954-12       Impact factor: 5.958

Review 2.  NIH conference. Clinical applications of corticotropin-releasing factor.

Authors:  G P Chrousos; T H Schuermeyer; J Doppman; E H Oldfield; H M Schulte; P W Gold; D L Loriaux
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

3.  Isolated adrenocorticotropin deficiency associated with polyglandular failure.

Authors:  I Kojima; I Nejima; E Ogata
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

4.  Responsiveness of hypophyseal-adrenocortical axis to repetitive administration of synthetic ovine corticotropin-releasing hormone in patients with isolated adrenocorticotropin deficiency.

Authors:  Y Koide; S Kimura; S Inoue; M Ikeda; K Uchida; J Ando; A Shimizu; K Oda; M Itakura; I Nabeshima
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

5.  Combined hypothalamic hypothyroidism and secondary adrenal insufficiency. Misdiagnosed as primary hypothyroidism.

Authors:  R V Farese; M E Rodriguez; B C O'Malley; E Jamieson; R J Pollet
Journal:  Arch Intern Med       Date:  1979-01

6.  Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.

Authors:  T Tsukada; Y Nakai; T Koh; S Tsujii; M Inada; M Nishikawa; H Shinoda; I Kawai; N Takezawa; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

7.  Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency.

Authors:  A J Richtsmeier; R A Henry; J M Bloodworth; E N Ehrlich
Journal:  Arch Intern Med       Date:  1980-09

8.  Isolated ACTH deficiency and primary hypothyroidism.

Authors:  M J Miller; T V Horst
Journal:  Acta Endocrinol (Copenh)       Date:  1982-04

9.  Isolated adrenocorticotrophic hormone (ACTH) deficiency associated with acute adrenal crisis.

Authors:  I Jialal; R K Desai; I C Maharaj; A S Pala; S M Joubert
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

Review 10.  CRH as a diagnostic and heuristic tool in hypothalamic-pituitary diseases.

Authors:  A R Hermus; G F Pieters; G J Pesman; T J Benraad; A G Smals; P W Kloppenborg
Journal:  Horm Metab Res Suppl       Date:  1987
View more
  2 in total

1.  Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.

Authors:  Masaaki Yamamoto; Anat Ben-Shlomo; Hiraku Kameda; Hidenori Fukuoka; Nan Deng; Yan Ding; Shlomo Melmed
Journal:  JCI Insight       Date:  2018-10-04

2.  Isolated adrenocorticotropic hormone deficiency secondary to hypothalamic deficit of corticotropin releasing hormone.

Authors:  A Velardo; M Pantaleoni; G Zizzo; G Del Rio; F Coletta; C Carani; P Marrama
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.